ro 8-0576 has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 1 studies
| Studies (ro 8-0576) | Trials (ro 8-0576) | Recent Studies (post-2010) (ro 8-0576) | Studies (6-methyl-2-(phenylethynyl)pyridine) | Trials (6-methyl-2-(phenylethynyl)pyridine) | Recent Studies (post-2010) (6-methyl-2-(phenylethynyl)pyridine) |
|---|---|---|---|---|---|
| 214 | 63 | 67 | 543 | 0 | 185 |
| Protein | Taxonomy | ro 8-0576 (IC50) | 6-methyl-2-(phenylethynyl)pyridine (IC50) |
|---|---|---|---|
| Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 6.2333 | |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 0.0129 | |
| Metabotropic glutamate receptor 5 | Homo sapiens (human) | 0.0199 | |
| Amine oxidase [flavin-containing] A | Mus musculus (house mouse) | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Paolo, T; Grégoire, L; Morin, N; Morissette, M | 1 |
1 other study(ies) available for ro 8-0576 and 6-methyl-2-(phenylethynyl)pyridine
| Article | Year |
|---|---|
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Brain; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Levodopa; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Protein Binding; Pyridines; Serotonin | 2015 |